IT 1S well recognized that a bronchial carcinoma may be occasionally responsible for a syndrome associated with the inappropriate secretion of antidiuretic hormone (ADH) (Bartter & Schwartz, 1967) . A similar water and electrolyte imbalance has been encountered in patients suffering from myxoedema or from various intracranial lesions (Haden & Knox, 1965; Neilson & Thorn, 1965 The appearance of the skin, the low pulse rate and the character of the ECG complexes were all suggestive of hypothyroidism. The 24-hr 131I uptake was 8%; the ratio of bound to free 131I at 48 hr was 0-07-0-28% of the dose per litre; 43% of the dose was excreted in the urine in 0-8 hr, 23% at 8-24 hr and 4% at 24-48 hr. These findings confirmed that the patient was mildly hypothyroid.
The electrolyte disturbance was further investigated. The plasma osmolality was 248 m-osmoles/l, but the urine osmolality normal at 298 m-osmoles/l. A 24-hr collection of urine was assayed for ADHlike activity. The recorded level of 18±6 mU, while above the normal limit of 10 mU was less than the 25-30 mU necessary to provide conclusive evidence of inappropriate ADH secretion.
Attempts at restricting the subject's fluid intake were unsuccessful, and he was treated with fludrocortisone acetate in a dose of 0-3 mg daily. This had no effect upon the serum electrolyte levels. The mild hypothyroidism was corrected with /-sodium thyroxine in a dose of 0-05 mg daily.
Over (Bartter & Schwartz, 1967) . All these criteria were established in the patient presented above.
Symptoms and signs of sodium depletion include personality changes, irritability and confusion. Muscle weakness, diminished tendon reflexes and upgoing plantar responses may also be encountered (Bartter & Schwartz, 1967 (Haden & Knox, 1965) . The focal signs of the EEG, coupled with the history of head injury, suggested this explanation, but the negative necropsy findings now make this seem less probable. Inappropriate ADH secretion may occur with myxoedema, and can be corrected, in this situation, by the administration of I-sodium thyroxine. The physiological basis of these observations is obscure (Nielsen & Thorn, 1965) . There was clinical and laboratory evidence of myxoedema in the case under discussion, but the histological appearance of the thyroid gland was normal. It is possible that the electrolyte disturbance could have caused the thyroid dysfunction. Barraclough, Jones & Lee (1966) (Barraclough et al., 1966) .
Various bio-assay techniques have been devised which demonstrate high concentrations of an ADHlike substance in oat cell tumours associated with electrolyte disturbances. Its pharmacological properties resemble those of arginine-vasopressin (Bower, Mason & Forsham, 1964; Lee, Jones & Barraclough, 1964; de Souza, Delaere & Berde, 1965; Barraclough et al., 1966; Godley & Locke, 1968) . Other investigators have demonstrated immunological similarities between the tumour extract and vasopressin (Verherr et al., 1968) . These studies suggest that the tumour actually produces ADH. The alternative, that the cancer merely concentrates material secreted by the pituitary, seems less likely.
A reduction in the urinary output caused by continuous hypersecretion of ADH produces a marked increase in volume of the total body water. The most marked increase is in the intracellular compartment, though there is also a slight expansion of fluid in the plasma and interstitial spaces. This is associated with an influx of sodium into the cells, at the expense of the extracellular compartment (Grantham, Brown & Schloerb, 1965; Kaye, 1966) . The excretion of normal or increased quantities of sodium in the presence of hyponatraemia is related to an inhibition of sodium reabsorption by the proximal renal tubules. This would appear to be a direct response by the tubules to an expansion in the extracellular fluid volume (Bartter & Schwartz, 1967 ).
An improvement in symptoms, and correction of the electrolyte disturbance, may be achieved by restricting the fluid intake (Thorn & Transbol, 1963 (Bartter & Schwartz, 1967) . Fludrocortisone reduces sodium excretion if given in large doses, but it does not solve the basic problem of water retention (Ross, 1963) . Physiological doses of fludrocortisone may cause a paradoxical increase in sodium loss (Ivy, 1961) . A direct attack on the tumour by surgery, radiotherapy or cytotoxic therapy can be extremely effective in this syndrome (Ivy, 1961; Godley & Locke, 1968; Thorn & Transbol, 1968) . This was not attempted in the case discussed because of early uncertainty over the diagnosis of bronchial cardinoma, and the possibility of the electrolyte disturbance being related to hypothyroidism or intracranial tumour.
